|
|
|
|
| LEADER |
01516nam a2200277 u 4500 |
| 001 |
EB002000182 |
| 003 |
EBX01000000000000001163083 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 020 |
|
|
|a 9789283212508
|
| 020 |
|
|
|a 9283212509
|
| 245 |
0 |
0 |
|a Pharmaceutical drugs
|h Elektronische Ressource
|
| 260 |
|
|
|a Lyon
|b IARC ; [Geneva, Switzerland] : Distributed for the International Agency for Research on Cancer by the Secretariat of the World Health Organization
|c 1990, 1990
|
| 300 |
|
|
|a 415 p
|
| 505 |
0 |
|
|a Includes bibliographical references and index
|
| 653 |
|
|
|a Neoplasms / chemically induced / https://id.nlm.nih.gov/mesh/D009369Q000139
|
| 653 |
|
|
|a Drug-Related Side Effects and Adverse Reactions / https://id.nlm.nih.gov/mesh/D064420
|
| 710 |
2 |
|
|a IARC Working Group on the Evaluation of Carcinogenic Risks to Humans
|
| 710 |
2 |
|
|a International Agency for Research on Cancer
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a IARC monographs on the evaluation of carcinogenic risks to humans
|
| 500 |
|
|
|a "This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 17-24 October 1989.". - At head of title: World Health Organization, International Agency for Research on Cancer
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK526176
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|